AK-OTOF is a gene therapy intended for the treatment of otoferlin gene-mediated hearing loss. Learn to Trade and Invest at Benzinga Trading School!
https://www.google.com/url?rct=j&sa=t&url=https://www.benzinga.com/general/biotech/21/08/22445098/akouos-hearing-loss-gene-therapy-poised-to-receive-orphan-drug-tag-in-europe&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFvKOJWOJm8be0rVXLu5qkTePkUjw
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.